SG Americas Securities’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-13,935
| Closed | -$18K | – | 3075 |
|
2024
Q4 | $18K | Buy |
+13,935
| New | +$18K | ﹤0.01% | 2639 |
|
2020
Q3 | – | Sell |
-20,418
| Closed | -$62K | – | 2428 |
|
2020
Q2 | $62K | Buy |
20,418
+7,542
| +59% | +$22.9K | ﹤0.01% | 3038 |
|
2020
Q1 | $25K | Buy |
+12,876
| New | +$25K | ﹤0.01% | 2764 |
|
2014
Q3 | – | Sell |
-24,744
| Closed | -$342K | – | 2239 |
|
2014
Q2 | $342K | Buy |
+24,744
| New | +$342K | ﹤0.01% | 1621 |
|